Evidence map›Paper›PMID 39451237›Full record

ArticleCells2024

Association Between Systemic Neuroinflammation, Pain Perception and Clinical Status in Fibromyalgia Patients: Cross-Sectional Study.

María Elena González-Álvarez, Víctor Riquelme-Aguado, Ángela González-Pérez, Rosa Murillo-Llergo, María Manjón-Olmedillas, Silvia Turroni, Giacomo Rossettini, Jorge Hugo Villafañe

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Do Fibromyalgia Patients Have a Preferred Resistance Training Volume? Protocol for a Randomized Crossover Clinical Trial.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

María Elena González-ÁlvarezEscuela Internacional de Doctorado, Rey Juan Carlos University, 28008 Madrid, Spain.ORCID 0000-0002-2823-8673
Víctor Riquelme-AguadoDepartment of Basic Health Sciences, Rey Juan Carlos University, 28933 Madrid, Spain.ORCID 0000-0002-3914-7355
Ángela González-PérezLaboratorio de Análisis Clínicos de la Dra. González Pérez, 28020 Madrid, Spain.
Rosa Murillo-LlergoLaboratorio de Análisis Clínicos de la Dra. González Pérez, 28020 Madrid, Spain.
María Manjón-OlmedillasLaboratorio de Análisis Clínicos de la Dra. González Pérez, 28020 Madrid, Spain.
Silvia TurroniUnit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.ORCID 0000-0003-2345-9482
Giacomo RossettiniDepartment of Physiotherapy, Faculty of Sport Sciences, Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Spain.ORCID 0000-0002-1623-7681
Jorge Hugo VillafañeDepartment of Physiotherapy, Faculty of Sport Sciences, Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Spain.ORCID 0000-0002-3239-7626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia (FM) is characterized by chronic pain and a complex array of symptoms, with neuroinflammation implicated in its pathophysiology.

methodsThis study aimed to explore the association between neuroinflammation, measured through interleukin levels (IL-1, IL-6, IL-8), and clinical outcomes in FM patients. Using a cross-sectional study design, blood levels of these interleukins were correlated with pain severity and disability, assessed via the Fibromyalgia Impact Questionnaire (FIQ) and pain measures.

resultsResults indicated that IL-6 and IL-8 may particularly serve as biomarkers for pain severity and disability in FM patients, showing significant associations with worse clinical outcomes. Elevated IL-8 levels, for instance, correlated strongly with increased pain perception and higher disability scores.

conclusionsThese findings suggest that specific interleukins are not only elevated in FM but are actively involved in the modulation of pain and disability, underscoring the role of systemic neuroinflammation in the clinical severity of FM. This study contributes to a deeper understanding of the inflammatory mechanisms in FM and underscores the potential of targeting interleukins in therapeutic strategies.

Indexed as

FibromyalgiaNeuroinflammatory DiseasesPain PerceptionAdultBiomarkersCross-Sectional StudiesFemaleHumansInflammationInterleukin-6Interleukin-8MaleMiddle AgedPain MeasurementSurveys and QuestionnairesBiomarkersInterleukin-6Interleukin-8fibromyalgiainterleukinsneuroinflammation

Identifiers

PMID39451237
PMCPMC11506720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.